Organon & Co. (OGN) NYSE
13.38
+0.02(+0.15%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
13.38
+0.02(+0.15%)
Currency In USD
| Market Cap | 1.86B |
| Enterprise Value | 10.09B |
| P/E Ratio | 14.16 |
| PEG Ratio | -0.21 |
| Price/Sales Ratio | 0.57 |
| Price/Book Ratio | 3.86 |
| Enterprise/Revenue | 1.78 |
| Enterprise/EBITDA | 8.28 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.04 |
| Operating Margin | 0.19 |
| Return On Assets | 0.02 |
| Return On Equity | 0.3 |
| Revenue | 6.22B |
| Revenue/Share | 23.67 |
| Gross Profit | 3.36B |
| EBITDA | 1.28B |
| Net Income | 187M |
| Diluted EPS | 0.72 |
| Total Cash | 1.12B |
| Total Cash/Share | 4.29 |
| Total Debt | 8.57B |
| Total Debt/Equity | 9.49 |
| Current Ratio | 1.97 |
| Book Value Per Share | 3.47 |
| 52-Week Change | 44.65 |
| 52-Week High | 13.48 |
| 52-Week Low | 5.69 |
| Moving Average 50 Days | 10.56 |
| Moving Average 200 Days | 8.85 |
| Average Volume | 8.72M |
| Shares Outstanding | 262.6M |
| % Held by Institutions | 76.79 |
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 0.6 |
| Payout Ratio | 0.09 |
| Last Split Factor | N/A |
| Last Split Date | N/A |